Dominant SCN2A Mutation Causes Familial Episodic Ataxia and Impairment of Speech Development

Abstract

Mutations in SCN2A are associated with a heterogeneous clinical spectrum including epilepsy and autism. Here, we have identified a peculiar phenotype associated with vaccination related exacerbations of ataxia. We report the first family with three individuals affected by SCN2A-associated episodic ataxia (EA) with impaired speech development. The index patient manifested his first episode of subacute cerebellar ataxia at the age of 12 months, 3 weeks after vaccinations for measles, mumps, rubella, and varicella. Cranial magnetic resonance imaging showed a lesion of the left cerebellar hemisphere, which was first considered as a potential cause of the ataxia. The patient fully recovered within 3 weeks, but developed three very similar episodes of transient ataxia within the following 24 months. Whole exome sequencing of the index patient revealed a heterozygous autosomal-dominant mutation in SCN2A (NM_021007, c.4949T > C; p.L1650P), which was confirmed in the likewise affected mother, and was then also identified in the younger brother who developed the first episode of ataxia. We hereby extend the recently described spectrum of SCN2A-associated neurologic disorders, emphasizing that SCN2A mutations should also be considered in familial cases of EA. Coincidental imaging findings or other associated events such as immunizations should not protract genetic investigations.

Keywords

ataxia - exome sequencing - ion channel - Na_V1.2 - SCN2A - vaccinations

^* Both authors are equal corresponding authors.

• References

• 1 Liao Y, Deprez L, Maljevic S. , et al. Molecular correlates of age-dependent seizures in an inherited neonatal-infantile epilepsy. Brain 2010; 133 (Pt 5): 1403-1414
• 2 Schaller KL, Caldwell JH. Expression and distribution of voltage-gated sodium channels in the cerebellum. Cerebellum 2003; 2 (01) 2-9
• 3 Liao Y, Anttonen AK, Liukkonen E. , et al. SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain. Neurology 2010; 75 (16) 1454-1458
• 4 Hu W, Tian C, Li T, Yang M, Hou H, Shu Y. Distinct contributions of Na(v)1.6 and Na(v)1.2 in action potential initiation and backpropagation. Nat Neurosci 2009; 12 (08) 996-1002
• 5 Scheffer IE, Berkovic S, Capovilla G. , et al. ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology. Epilepsia 2017; 58 (04) 512-521
• 6 Berkovic SF, Heron SE, Giordano L. , et al. Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy. Ann Neurol 2004; 55 (04) 550-557
• 7 Heron SE, Crossland KM, Andermann E. , et al. Sodium-channel defects in benign familial neonatal-infantile seizures. Lancet 2002; 360 (9336): 851-852
• 8 Rauch A, Wieczorek D, Graf E. , et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 2012; 380 (9854): 1674-1682
• 9 Sanders SJ, Murtha MT, Gupta AR. , et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012; 485 (7397): 237-241
• 10 Wolff M, Johannesen KM, Hedrich UBS. , et al. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders. Brain 2017; 140 (05) 1316-1336
• 11 Johannesen KM, Miranda MJ, Lerche H, Møller RS. Letter to the editor: confirming neonatal seizure and late onset ataxia in SCN2A Ala263Val. J Neurol 2016; 263 (07) 1459-1460
• 12 Schwarz N, Hahn A, Bast T. , et al. Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia. J Neurol 2016; 263 (02) 334-343
• 13 Gorman KM, King MD. SCN2A p.Ala263Val variant a phenotype of neonatal seizures followed by paroxysmal ataxia in toddlers. Pediatr Neurol 2017; 67: 111-112
• 14 Leach EL, van Karnebeek CDM, Townsend KN, Tarailo-Graovac M, Hukin J, Gibson WT. Episodic ataxia associated with a de novo SCN2A mutation. Eur J Paediatr Neurol 2016; 20 (05) 772-776
• 15 Wang H, Salter CG, Refai O. , et al. Choline transporter mutations in severe congenital myasthenic syndrome disrupt transporter localization. Brain 2017; 140 (11) 2838-2850
• 16 Bamborschke D, Pergande M, Becker K. , et al. A novel mutation in sphingosine-1-phosphate lyase causing congenital brain malformation. Brain Dev 2018; 40 (06) 480-483
• 17 Trump N, McTague A, Brittain H. , et al. Improving diagnosis and broadening the phenotypes in early-onset seizure and severe developmental delay disorders through gene panel analysis. J Med Genet 2016; 53 (05) 310-317
• 18 Schattling B, Fazeli W, Engeland B. , et al. Activity of Na_V1.2 promotes neurodegeneration in an animal model of multiple sclerosis. JCI Insight 2016; 1 (19) e89810
• 19 Lerche H, Peter W, Fleischhauer R. , et al. Role in fast inactivation of the IV/S4-S5 loop of the human muscle Na+ channel probed by cysteine mutagenesis. J Physiol 1997; 505 (Pt 2): 345-352
• 20 Alekov AK, Peter W, Mitrovic N, Lehmann-Horn F, Lerche H. Two mutations in the IV/S4-S5 segment of the human skeletal muscle Na+ channel disrupt fast and enhance slow inactivation. Neurosci Lett 2001; 306 (03) 173-176
• 21 Ohba C, Kato M, Takahashi S. , et al. Early onset epileptic encephalopathy caused by de novo SCN8A mutations. Epilepsia 2014; 55 (07) 994-1000
• 22 Fukasawa T, Kubota T, Negoro T. , et al. A case of recurrent encephalopathy with SCN2A missense mutation. Brain Dev 2015; 37 (06) 631-634
• 23 Feenstra B, Pasternak B, Geller F. , et al. Common variants associated with general and MMR vaccine-related febrile seizures. Nat Genet 2014; 46 (12) 1274-1282